Skip to content

Irritable Bowel Syndrome Hypnotherapy

Outcome Effectiveness Predictors of Irritable Bowel Syndrome Hypnotherapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01248013
Enrollment
89
Registered
2010-11-25
Start date
2005-09-30
Completion date
2009-12-31
Last updated
2011-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Brief summary

The primary goal of the study was whether gut focused hypnotherapy, in a group format, was successful in reduction of symptoms in patients with irritable bowel syndrome. The secondary goal was to see if any outcome predictors could be determined.

Detailed description

Patients with Irritable Bowel Syndrome entering a group hypnotherapy program are asked to complete a series of questionnaires at the outset, and repeat a symptom severity scale at intervals over the one year period after termination of treatment. Eligibility was limited to patients with age greater than 20. Outcome measures were improvement in symptom score. Outcome predictors studied included quality of relationships, measured with a Quality of Relationship Inventory and attribution of IBS to physical or emotional cause, measured with a Mind-Body IBS Questionnaire, both administered before onset of hypnotherapy.

Interventions

BEHAVIORALgut focused hypnotherapy

7 session hypnotherapy protocol designed for irritable bowel syndrome

Sponsors

Mind-Body Digestive Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of irritable bowel syndrome by Rome II criteria, age 20 and older

Exclusion criteria

* Age below 20

Design outcomes

Primary

MeasureTime frameDescription
Effectiveness of Group Hypnotherapy in Irritable Bowel Syndromeone yearassessed by symptom severity scale given before treatment began and after 7 bi-weekly sessions, at 3 months, 6 months and 12 months
Percentage of Patients With Significant Reduction in Their IBS Symptom Severity Score One Year After Completion of Therapy.One year after termination of treatmentThe IBS Symptom Severity Scale has four components, severity of abdominal pain, number of days with pain in past 10 days, abdominal distension, bowel habit and interference with life in general. Maximum score is 500, minimum score is 0. The lower the score, the lower the symptom severity. Participants are considered clinically improved if they have a reduction in score of 50 points or greater.

Secondary

MeasureTime frameDescription
Outcome Predictorsone yearto determine whether relationship quality, or attribution of symptoms to physical or emotional causation correlated with result

Countries

United States

Participant flow

Recruitment details

Patients were recruited at their initial visit to an IBS treatment center, on a purely voluntary basis into a group hypnotherapy program, from 2005 to 2009. 75 patients were entered into the study. Another 14 filled out initial questionnaires but then declined to enter treatment or dropped out after 1 or 2 sessions.

Pre-assignment details

There was no control group assignment in this preliminary study which was designed to see if hypnotherapy, already proven effective in individual treatment was effective when using a group format.

Participants by arm

ArmCount
Group Hypnotherapy for Irritable Bowel Syndrome
IBS subjects, in groups of 3 to 8 participants, received a specific gut focused hypnotherapy protocol. Meetings were bi-weekly, seven in all, and each meeting was 45 minutes in length. CD's were distributed for use at home between meetings.
89
Total89

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject14

Baseline characteristics

CharacteristicGroup Hypnotherapy for Irritable Bowel Syndrome
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
9 Participants
Age, Categorical
Between 18 and 65 years
80 Participants
Age Continuous45.9 years
STANDARD_DEVIATION 14.4
Region of Enrollment
United States
89 participants
Sex: Female, Male
Female
56 Participants
Sex: Female, Male
Male
33 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 89
serious
Total, serious adverse events
0 / 89

Outcome results

Primary

Effectiveness of Group Hypnotherapy in Irritable Bowel Syndrome

assessed by symptom severity scale given before treatment began and after 7 bi-weekly sessions, at 3 months, 6 months and 12 months

Time frame: one year

Primary

Percentage of Patients With Significant Reduction in Their IBS Symptom Severity Score One Year After Completion of Therapy.

The IBS Symptom Severity Scale has four components, severity of abdominal pain, number of days with pain in past 10 days, abdominal distension, bowel habit and interference with life in general. Maximum score is 500, minimum score is 0. The lower the score, the lower the symptom severity. Participants are considered clinically improved if they have a reduction in score of 50 points or greater.

Time frame: One year after termination of treatment

ArmMeasureValue (NUMBER)
Group Hypnotherapy for Irritable Bowel SyndromePercentage of Patients With Significant Reduction in Their IBS Symptom Severity Score One Year After Completion of Therapy.60 percentage of participants
Secondary

Outcome Predictors

to determine whether relationship quality, or attribution of symptoms to physical or emotional causation correlated with result

Time frame: one year

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026